Board of Directors

Executive Committee :

David Main, President & CEO, Aquinox Pharmaceuticals (Chairman)

Paul Petrelli, President & General Manager, Canada, Biogen Canada Inc. (Vice Chair)

Kevin Leshuk, General Manager, Celgene Inc. (Treasurer)

Andrew Casey, President & CEO, BIOTECanada (Secretary)

Brad Thompson, President & CEO, Oncolytics Biotech Inc. (past-Chair)

 

Directors:

Roberto Bellini, President & CEO, Bellus Health

Brian Bloom, President, Bloom Burton & Co.

Neal Carter, President & Founder, Okanagan Specialty Fruits

Natalie Dakers, CEO, Accel-Rx Health Sciences

Michel Fortin, President & CEO, Prevtec Microbia Inc.

Diane Gosselin, President & CEO, CQDM

John Haslam, General Manager, Alexion Pharmaceuticals

Brian Hilberdink, President, Novo Nordisk Canada Inc.

Mark Lievonen, President, Sanofi Pasteur Limited

A.J. (Sandy) Marshall, Chairman, Bioindustrial Innovation Canada

Gordon McCauley, Partner, Viable Healthworks Corporation

John Norman, Partner, Gowling Lafleur Henderson LLP

Greg Penner, President & CEO, NeoVentures Biotechnology Inc.

Sanj Singh, President & CEO, Ade Therapeutics

Shermaine Tilley, Managing Partner, CTI Life Sciences Fund

Oliver Technow, CEO, BioVectra Inc.

Eric Tse, General Manager, Shire Pharma Canada ULC

Dan Wattier, CEO, ImStar Therapeutics

Partnership Program

Platinum

AbbVie

Biogen Idec

Genzyme

vwr

Gold

Alexion